These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

828 related items for PubMed ID: 19698015

  • 1. Excretion of antimicrobials used to treat methicillin-resistant Staphylococcus aureus infections during lactation: safety in breastfeeding infants.
    Mitrano JA, Spooner LM, Belliveau P.
    Pharmacotherapy; 2009 Sep; 29(9):1103-9. PubMed ID: 19698015
    [Abstract] [Full Text] [Related]

  • 2. Treatment of infections caused by resistant Staphylococcus aureus.
    Anstead GM, Quinones-Nazario G, Lewis JS.
    Methods Mol Biol; 2007 Sep; 391():227-58. PubMed ID: 18025681
    [Abstract] [Full Text] [Related]

  • 3. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST.
    Clin Infect Dis; 2007 Sep 15; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [Abstract] [Full Text] [Related]

  • 4. Oral antibiotic treatment for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: review of the literature.
    Khawcharoenporn T, Alan T.
    Hawaii Med J; 2006 Oct 15; 65(10):290-3. PubMed ID: 17194061
    [Abstract] [Full Text] [Related]

  • 5. Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.
    Drew RH.
    Pharmacotherapy; 2007 Feb 15; 27(2):227-49. PubMed ID: 17253914
    [Abstract] [Full Text] [Related]

  • 6. Treatment of infections due to resistant Staphylococcus aureus.
    Anstead GM, Cadena J, Javeri H.
    Methods Mol Biol; 2014 Feb 15; 1085():259-309. PubMed ID: 24085702
    [Abstract] [Full Text] [Related]

  • 7. Extremely low excretion of daptomycin into breast milk of a nursing mother with methicillin-resistant Staphylococcus aureus pelvic inflammatory disease.
    Buitrago MI, Crompton JA, Bertolami S, North DS, Nathan RA.
    Pharmacotherapy; 2009 Mar 15; 29(3):347-51. PubMed ID: 19249952
    [Abstract] [Full Text] [Related]

  • 8. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR, Golik MV, Davidson L.
    Am J Ther; 2009 Mar 15; 16(4):333-8. PubMed ID: 19617720
    [Abstract] [Full Text] [Related]

  • 9. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N.
    J Drugs Dermatol; 2007 Jan 15; 6(1):97-103. PubMed ID: 17373167
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B, Merckoll P, Melby KK.
    Scand J Infect Dis; 2007 Jan 15; 39(11-12):1059-62. PubMed ID: 17852934
    [Abstract] [Full Text] [Related]

  • 11. Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs.
    Sabol KE, Echevarria KL, Lewis JS.
    Ann Pharmacother; 2006 Jun 15; 40(6):1125-33. PubMed ID: 16735661
    [Abstract] [Full Text] [Related]

  • 12. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
    Shapiro A, Raman S, Johnson M, Piehl M.
    N C Med J; 2009 Jun 15; 70(2):102-7. PubMed ID: 19489364
    [Abstract] [Full Text] [Related]

  • 13. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.
    Smith K, Perez A, Ramage G, Gemmell CG, Lang S.
    Int J Antimicrob Agents; 2009 Apr 15; 33(4):374-8. PubMed ID: 19101124
    [Abstract] [Full Text] [Related]

  • 14. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature.
    Ruhe JJ, Monson T, Bradsher RW, Menon A.
    Clin Infect Dis; 2005 May 15; 40(10):1429-34. PubMed ID: 15844065
    [Abstract] [Full Text] [Related]

  • 15. Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care.
    Tverdek FP, Crank CW, Segreti J.
    Crit Care Clin; 2008 Apr 15; 24(2):249-60, vii-viii. PubMed ID: 18361944
    [Abstract] [Full Text] [Related]

  • 16. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.
    Le J, Lieberman JM.
    Pharmacotherapy; 2006 Dec 15; 26(12):1758-70. PubMed ID: 17125437
    [Abstract] [Full Text] [Related]

  • 17. Antibiotic selection for MRSA: case presentations and review of the literature.
    Hanson MR, Chung CL.
    J Drugs Dermatol; 2009 Mar 15; 8(3):281-6. PubMed ID: 19271378
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO, Hall RG.
    Ann Pharmacother; 2007 Feb 15; 41(2):235-44. PubMed ID: 17299012
    [Abstract] [Full Text] [Related]

  • 19. Methicillin-resistant Staphylococcus aureus infections.
    Bartlett JG.
    Top HIV Med; 2008 Dec 15; 16(5):151-5. PubMed ID: 19106430
    [Abstract] [Full Text] [Related]

  • 20. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ, Zaoutis TE, Troxel AB, Loh A, Keren R.
    Pediatrics; 2009 Jun 15; 123(6):e959-66. PubMed ID: 19470525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.